Earnings Call/Transcript
Narayana Hrudayalaya Earnings Call Audio Uploaded
Narayana Hrudayalaya Ltd: Audio recording of the earnings call for Q1 (quarter ended June 30, 2026) held on August 03, 2026 has been uploaded to the company's website.

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Bearish
3
Neutral
5
Bullish
6
Bearish
26
Neutral
5
Bullish
15
Bearish
23
Neutral
0
Bullish
9

Healthcare Services
Hospital
39,224 Cr
Low Risk
48.1
64.4
1.5
8.6
2,094.30
1,564.25
Sales CAGR
Profit CAGR
ROE
ROCE

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Narayana Hrudayalaya Ltd (NH) is currently trading at 1,919.35 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Narayana Hrudayalaya Limited is a multi‑speciality and super‑speciality healthcare operator founded by Dr. Devi Prasad Shetty, running a network of hospitals, clinics and management‑run facilities across India and international markets including Cayman Islands and the UK, offering tertiary care, robotic procedures, oncology and cardiac services alongside integrated care and an insurance business. Recent quarters show meaningful margin expansion in the India portfolio driven by a multi‑year transformation: payor‑mix optimisation, higher‑realisation cases including robotic cardiac and bone marrow transplants, and technology infusion have driven 150–200 bps YoY margin improvement in the India business with management intent to sustain these gains where possible. The Group has accelerated international footprint via a material UK acquisition (Practice Plus) and continued Cayman investment; the UK deal was funded with substantial debt (GBP 150m) and equity (GBP 45m) and is expected to be EBITDA neutral to mildly accretive over time after integration and operational efficiencies, while creating short‑term ROCE normalization. Narayana is investing in an integrated care stack — clinics, pharmacies, and insurance (NHIC) — accepting near‑term losses to build distribution and cross‑sell; management is deliberately merging clinic operations into NHL and reporting insurance separately, with losses narrowing but breakeven timelines still uncertain as investments continue.
Over the past 52 weeks, Narayana Hrudayalaya Ltd has traded between a low of ₹1,564.25 and a high of ₹2,094.30. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Narayana Hrudayalaya Ltd has a market capitalization of approximately 39,223.99. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Narayana Hrudayalaya Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 48.06 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 39,223.99 Cr, Narayana Hrudayalaya Ltd is classified as a Mid Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Narayana Hrudayalaya Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Narayana Hrudayalaya Ltd is 48.06. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Consolidated revenue from operations was reported at ₹2,684 crore for Q1 FY27 (also presented as ₹26,836.34 million).
Consolidated operating revenue/revenue from operations was reported at about ₹2,684 crore (₹26,836.34 million), up from about ₹1,507 crore a year earlier.
The 26th AGM is scheduled for Friday, August 14, 2026 at 11:30 A.M. (IST) through VC/OAVM.
The company reported consolidated total operating revenue of ₹2,593.8 crore and adjusted EBITDA of ₹539.4 crore for Q4 FY26.
Earnings Call/Transcript
Narayana Hrudayalaya Ltd: Audio recording of the earnings call for Q1 (quarter ended June 30, 2026) held on August 03, 2026 has been uploaded to the company's website.
Earnings Call/Transcript
Narayana Hrudayalaya Ltd: audio recording of the earnings call for the quarter ended June 30, 2026 held on August 03, 2026 has been uploaded to the company website.
Investor Presentation
Narayana Hrudayalaya Ltd submitted a revised investor presentation for the quarter ended June 30, 2026 (Q1 FY27) containing operational and financial highlights, revenues, EBITDA, PAT and other metrics.
Investor Presentation
Narayana Hrudayalaya released a revised investor presentation for quarter ended 30-Jun-2026 (Q1 FY27) showing consolidated operating revenues ₹26,836 Mn (+78% YoY), EBITDA ₹5,052 Mn, PAT ₹2,073 Mn and net debt ₹19,671 Mn.
Financial Results
Narayana Hrudayalaya Ltd published newspaper advertisement of unaudited standalone and consolidated financial results for quarter ended June 30, 2026 (Q1 FY27). Advertisement published Aug 2, 2026 in Financial Express and Vijayavani.
Financial Results
Narayana Hrudayalaya Ltd published a newspaper extract of unaudited standalone and consolidated financial results for the quarter ended June 30, 2026; advertisement published on August 02, 2026.